Element Biosciences

Element Biosciences is a biotechnology company that develops sequencing and multiomic platforms. Its mission is to empower the scientific community with more freedom and flexibility to accelerate impact on humanity. The company has nearly 30 unique patents, its technology has been used in 400+ publications, and it has a global customer base spanning 40+ countries.

Element Biosciences is a San Diego biotechnology company developing genetic analysis tools. The company has launched the AVITI™ benchtop sequencing system and the AVITI24™ 5D Multiomics System. In July 2024, it announced $277 million in Series D financing led by Wellington Management. In April 2024, it launched the AVITI24™ 5D Multiomics System. In January 2023, it announced the $200 genome with the AVITI™ benchtop sequencing system. In August 2022, it announced a reagent price guarantee for the lifetime of the AVITI™ System.

• AVITI™

  Benchtop sequencing instrument with reimagined core technology to deliver flexibility and affordability while setting the standard for data quality.

• AVITI24™

  The first 5D multiomics system for spatial, single cell multiomics and high-quality affordable sequencing.

1. Opening the World of Biology to New Possibilities | Element Biosciences
2. San Diego Genomics & Life Science | Element Biosciences
3. Technology & Life Science Leadership | Element Biosciences
4. Element AVITI System Sequencing Instrument | Element Biosciences